Product Details

Cartalax (Joints)

Basic Info.

Cartalax is a short bioregulatory peptide with widespread systemic impact due to its effects on fibroblasts. It has been shown to benefit skin and other connective tissues as well as the kidneys. Research shows that Cartalax increases cell proliferation rates and beneficially alters the levels of various cytokines and signaling molecules associated with senescence. Overall, it increases cell health and proliferation while decreasing cell death. Cartalax is thought of as an anti-aging peptide, returning older cells to a more youthful state and prolonging overall tissue health.

Cartalax enhances joint function, making movement smoother and less painful. This improved mobility allows for a more active lifestyle and reduces the limitations caused by joint discomfort.

Areas of Expertise

• Leading-Edge Manufacturing Capabilityg
• Advanced R&D and State-of-the-Art Facilities
• Versatile and Scalable Packaging Solutions
• Certified Quality & International Compliance